Published :
Tables : 55
Figures : 51
Category : Healthcare
No. of Pages : 236
Report Code : HC-1013
Dermal fillers market is projected to value at a CAGR of over 13% during the forecast period of 2022-2028. Dermal fillers are injections used to fill out wrinkles and gives a smooth appearance to the skin. They can also be used to increase the volume of facial organs. They include collagen, hyaluronic acid, calcium hydroxyl apatite and others. Dermal fillers effects can be either temporary or permanent, depending on the type of fillers and used for facial reconstruction. Dermal collagen is used for triggering dermal metabolism and its effects last for three to four months. Hyaluronic acid is used for facial reappearance and its effects last for four months to six months. Calcium hydroxylapatite is used for facial augmentation and its effect last for 18 months and polymethylmethacrylate beads are used for permanent effect. The increasing importance of personal appearance in general population led to the potential growth of dermal fillers market. Along with this, rising awareness of minimally invasive cosmetic procedure led to rapid adoption. Further, changing demographics and rising living standards led to the potential growth of the market. Minimal invasive cosmetic procedures like dermal fillers more cost effects with fewer side effects compared to conventional cosmetic procedures. Dermal fillers market has witnessed double digit growth during the forecast period due to increasing penetration among developing countries. Additionally, increasing R&D investment to strengthen the product portfolio led to the development of new products in the forecast period. High awareness and penetration among the general population of developed economies like North America and Europe region account major share in global dermal fillers market. They are expected to remain dominant over the forecast period and witness stagnant growth rate. Asia Pacific is a fast growing region and expected to create an opportunistic space for both international and local manufacturers. Asia Pacific and Latin America is a fast growing region in the global Dermal Fillers market. Rest of the world is expected to account minor share in global market. Major market players include Allergan, Skin, & Vein Institute, LLC, Galderma Laboratories, L.P, Merz Pharma, Dr. Korman Laboratories, Sinclair Pharma, Teoxane Laboratories, Suneva Medical, SciVision Biotech Inc., Medytox. Dermal fillers market is expected to witness new player’s entry during the forecast period. Dermal Fillers Market Segmentation: By Filler Type • Calcium hydroxylapatite • Hyaluronic acid • Poly-alkylimide • Polylactic acid • Polymethylmethacrylate microspheres (PMMA) By Application • Scar Treatment • Wrinkle Correction Treatment • Lip Enhancement • Restoration of Volume/Fullness • Others By Product • Biodegradable o Temporary biodegradable o Semi-permanent biodegradable • Non-Biodegradable By End-User • Hospital • Cosmetic Clinics • Outpatient Centres • Beauty Centres • Academics By Region • Europe • North America • Asia Pacific • Latin America • Middle East and Africa Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global dermal filler market on the basis of by Filler Type, by Application, by Product, by End User and By Region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and an overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Dermal fillers are injections used to fill out wrinkles and gives a smooth appearance to the skin. They can also be used to increase the volume of facial organs. They include collagen, hyaluronic acid, calcium hydroxyl apatite and others. Dermal fillers effects can be either temporary or permanent, depending on the type of fillers and used for facial reconstruction. Dermal collagen is used for triggering dermal metabolism and its effects last for three to four months. Hyaluronic acid is used for facial reappearance and its effects last for four months to six months. Calcium hydroxylapatite is used for facial augmentation and its effect last for 18 months and polymethylmethacrylate beads are used for permanent effect.
The increasing importance of personal appearance in general population led to the potential growth of dermal fillers market. Along with this, rising awareness of minimally invasive cosmetic procedure led to rapid adoption. Further, changing demographics and rising living standards led to the potential growth of the market. Minimal invasive cosmetic procedures like dermal fillers more cost effects with fewer side effects compared to conventional cosmetic procedures. Dermal fillers market has witnessed double digit growth during the forecast period due to increasing penetration among developing countries. Additionally, increasing R&D investment to strengthen the product portfolio led to the development of new products in the forecast period.
High awareness and penetration among the general population of developed economies like North America and Europe region account major share in global dermal fillers market. They are expected to remain dominant over the forecast period and witness stagnant growth rate. Asia Pacific is a fast growing region and expected to create an opportunistic space for both international and local manufacturers. Asia Pacific and Latin America is a fast growing region in the global Dermal Fillers market. Rest of the world is expected to account minor share in global market.
Major market players include Allergan, Skin, & Vein Institute, LLC, Galderma Laboratories, L.P, Merz Pharma, Dr. Korman Laboratories, Sinclair Pharma, Teoxane Laboratories, Suneva Medical, SciVision Biotech Inc., Medytox. Dermal fillers market is expected to witness new player’s entry during the forecast period.
Dermal Fillers Market Segmentation:
By Filler Type
• Calcium hydroxylapatite • Hyaluronic acid • Poly-alkylimide • Polylactic acid • Polymethylmethacrylate microspheres (PMMA)
By Application
• Scar Treatment • Wrinkle Correction Treatment • Lip Enhancement • Restoration of Volume/Fullness • Others
By Product
• Biodegradable o Temporary biodegradable o Semi-permanent biodegradable • Non-Biodegradable
By End-User
• Hospital • Cosmetic Clinics • Outpatient Centres • Beauty Centres • Academics
By Region
• Europe • North America • Asia Pacific • Latin America • Middle East and Africa
Competitive Landscape:
FutureWise Takeaways
Objectives of the Study:
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Dermal Fillers Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Dermal Fillers Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Dermal Fillers Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Dermal Fillers Market, By Filler Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Calcium hydroxylapatite 7.2. Hyaluronic acid 7.3. Poly-alkylimide 7.4. Polylactic acid, 7.5. Polymethylmethacrylate microspheres (PMMA) 8. Dermal Fillers Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Scar Treatment 8.2. Wrinkle Correction Treatment 8.3. Lip Enhancement 8.4. Restoration of Volume/Fullness 8.5. Others 9. Dermal Fillers Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Biodegradable 9.1.1. Temporary biodegradable 9.1.2. Semi-permanent biodegradable 9.2. Non-Biodegradable 10. Dermal Fillers Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospital 10.2. Cosmetic Clinics 10.3. Outpatient Centres 10.4. Beauty Centres 10.5. Academics 11. North America Dermal Fillers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Dermal Fillers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Dermal Fillers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Dermal Fillers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Allergan 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Skin, & Vein Institute, LLC 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Galderma Laboratories, L.P 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Merz Pharma 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Dr. Korman Laboratories 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Sinclair Pharmampany Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Teoxane Laboratories 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Suneva Medical 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. SciVision Biotech Inc. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Medytox 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Dermal Fillers Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Dermal Fillers Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Dermal Fillers Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Dermal Fillers Market, By Filler Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Calcium hydroxylapatite 7.2. Hyaluronic acid 7.3. Poly-alkylimide 7.4. Polylactic acid, 7.5. Polymethylmethacrylate microspheres (PMMA)
8. Dermal Fillers Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Scar Treatment 8.2. Wrinkle Correction Treatment 8.3. Lip Enhancement 8.4. Restoration of Volume/Fullness 8.5. Others
9. Dermal Fillers Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Biodegradable 9.1.1. Temporary biodegradable 9.1.2. Semi-permanent biodegradable 9.2. Non-Biodegradable
10. Dermal Fillers Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Hospital 10.2. Cosmetic Clinics 10.3. Outpatient Centres 10.4. Beauty Centres 10.5. Academics
11. North America Dermal Fillers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Dermal Fillers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Dermal Fillers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Dermal Fillers Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Allergan 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Skin, & Vein Institute, LLC 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. Galderma Laboratories, L.P 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Merz Pharma 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Dr. Korman Laboratories 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. Sinclair Pharmampany Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. Teoxane Laboratories 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Suneva Medical 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. SciVision Biotech Inc. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10.Medytox 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics